Skip to main content
Fig. 2 | BMC Pulmonary Medicine

Fig. 2

From: Effect of furosemide in the treatment of high-altitude pulmonary edema

Fig. 2

Subgroup analysis of the pulmonary radiographic features and length of hospital stay in high-altitude pulmonary edema treated with furosemide. (A) CT Severity Score of high-altitude pulmonary edema patients among different subgroups before treatment. (B) CT Severity Score of high-altitude pulmonary edema patients among different subgroups after three days of treatment. (C) Difference in CT Severity Score of high-altitude pulmonary edema patients among different subgroups before and after treatment. (D) Length of hospital stay among high-altitude pulmonary edema patients in different subgroups. F1: Furosemide 20 mg daily used on the first day after admission. F2: Furosemide 20 mg daily used for the first two days after admission. F3: Furosemide 20 mg daily used for the first three days after admission

Back to article page